When depression will not lift, the search bar feels like action. It is open at midnight, it asks no questions, and it returns thousands of answers in a second. For a lot of people across the Midwest, that is where the looking starts, even if it is not where the deciding happens.
We wanted to know how people really approach a new depression treatment, so in June 2026 our poll went to 443 adults, each living somewhere in a ten-state stretch of the Midwest. The final, validated answers undercut several common assumptions about searching for care online. Here are five of those assumptions, checked.
Myth one: "Everyone researches online before seeing a doctor."
What we found: Far fewer people start online than you might expect. Only 12 percent of respondents would open their pursuit of ketamine or esketamine treatment with a solo search. By contrast, 56 percent would begin with their family doctor and 23 percent with psychiatry.
That does not mean people never search. It means most people treat a clinician, not a website, as the starting line. If you have been told you should "do your homework" before you are allowed to ask, you can let that go. Walking in with a question is a perfectly normal way to begin.
Myth two: "You have to know the treatment's name to find it."
What we found: Very few people know the names, and they search anyway. Spravato, a nasal esketamine with FDA approval for depression that other care has not relieved, drew a blank from 73 percent of the people we polled, and 6 percent could explain it.
An open text box let people write their own search, and the 319 who did described feelings, with entries like "depressed," "how to cope with my anxiety," and "help with depression." Almost none typed a drug name.
Searching in your own words is not a mistake. But it does mean search results will often show you general content and advertising rather than a map of specific, approved options. That is one reason to bring your questions to a clinician, who can translate "nothing is working" into a list of real choices.
Myth three: "Search results tell you which treatments are approved."
What we found: This one is about how the web works rather than a survey number, but it matters a great deal. Searching "ketamine for depression" can return a jumble of very different things:
- Esketamine nasal spray, sold as Spravato, the one option here with FDA approval for hard-to-treat depression, used only under supervision at certified clinics.
- IV ketamine infusion clinics, which use an approved anesthetic off-label for depression, with protocols that vary by clinic.
- At-home ketamine sold through telehealth, with much less supervision and a far grayer regulatory picture.
A clinic's website may not make these differences clear, and the words "ketamine therapy" get used for all three. Our respondents cared about the distinction, with 59 percent calling FDA approval big or decisive for them. If approval matters to you, ask a clinician directly which option is which.
Myth four: "Star ratings show whether a treatment fits me."
What we found: People want something more personal than a star rating. On who could get them to try this care, respondents gave their own doctor 74 percent. Online veterans or first responders they follow swayed 4 percent. Ads moved 2 percent; podcasters, 1 percent.
Reviews can tell you whether a clinic returns calls or runs on time. They cannot tell you whether a treatment is safe with your blood pressure, your other medications, or your history. That judgment requires someone who knows your chart.
Myth five: "Searching online is the fastest route to treatment."
What we found: Speed is complicated. Searching feels fast, and calling a clinic you found online can sometimes get you an appointment quickly. But for many people, the real bottleneck is insurance. When respondents could name just two things they want in a provider, coverage made 85 percent of the lists.
Covered care for depression that standard medicine has not fixed usually requires documentation of what you have already tried, and often a prior authorization. That paperwork tends to run through a doctor's office. A primary care visit that feels slower up front can turn out to be the shorter path to covered care.
So what is search actually good for?
Plenty. Used well, searching can help you:
- Find words for what you are feeling.
- Learn the names of options so you can ask about them.
- Find out which providers are near you, since 43 percent of respondents counted distance among their two main concerns.
- Prepare a list of questions for your appointment.
The shift is small but important. Search to prepare. Let a clinician help you decide.
A few questions to take from your research to the appointment
- "I read about esketamine and TMS. Could either fit my situation?"
- "Is the ketamine clinic I found offering an FDA-approved treatment, or something off-label?"
- "What would my insurance need before covering any of these?"
The limits of this article
This is survey research about how people seek care, not medical advice or clinical evidence. Esketamine is approved for specific uses and given only under supervision in certified settings, and Brain Recovery Centers keeps a clear page on what Spravato treatment involves for readers who want a reliable source. A clinician decides what suits you.
If your searching tonight includes words like "someone please help me," stop typing and reach 988 by phone or text. A trained person answers for the Suicide and Crisis Lifeline at every hour, without charge and in confidence.
Methodology
Pollfish study 395586438 drew on Pollfish panel members and ended June 23, 2026. Of its 443 completes, all from adults 18 through 64 living in Oklahoma, Ohio, Missouri, Minnesota, Illinois, Iowa, Wisconsin, Indiana, Nebraska and Kansas, 319 answered the open search question. We publish the whole-sample results, now validated. The research was paid for, and requested, by our publisher.